Market Access/ News/ News Cara’s Korsuva is first drug cleared for itching in dialysis patients Phil Taylor Cara Therapeutics, chronic kidney disease, dialysis, difelikefalin, Korsuva, pruritus, regulatory approval, Vifor Pharma 0 Comment One of the most common and challenging side effects for people undergoing dialysis for chronic kidney disease – Share X Cara’s Korsuva is first drug cleared for itching in dialysis patients https://pharmaphorum.com/news/caras-korsuva-is-first-drug-cleared-for-itching-in-dialysis-patients/